Semaglutide, liraglutide, and tirzepatide are all categorized as GLP-1 receptor agonists, meaning that they mimic the action of the GLP-1 hormone, which stimulates insulin. In mimicking the ...

For details, see the “What should be considered before taking Victoza?” section. Diabetes affects your metabolism. It causes high blood sugar due to problems making or using insulin in your body.

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

KELOWNA, BC / ACCESS Newswire / February 20, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that ...

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

"The action of liraglutide in patients with type 2 diabetes is largely due to an increase in insulin secretion from the pancreas,," Dandona explains, "But since type 1 diabetics have no insulin ...